Prostate cancer is the second most common cause of cancer in men. It commonly occurs in patients over the age of 50. Prostate cancer can be completely cured if detected in the early stages. That is why it is of vital importance that the diagnosis is performed by experts.
The key to curing prostate cancer is early diagnosis. Early diagnosis of prostate cancer is based on the test for prostate-specific antigen (PSA). Along with this test, other diagnostic procedures are available at Tel Aviv Sourasky Medical Center, including:
- Digital rectal examination
- Prostate biopsy
- Screening with CT , PET-CT, MRI, Prostate US
- Radio-isotope scan
Israeli specialists have successfully implemented an innovative and comprehensive diagnostic technique based on the test for the tumor cell surface marker – prostate-specific membrane antigen (PSMA). PSMA is a synthesized protein found on the surface of prostate tumor cells. It can also be present in healthy cells but in much smaller quantities. The new technique allows experts to determine the presence of tumors and metastases.